×
Log in
Upload File
Most Popular
Study
Business
Design
Technology
Travel
Explore all categories
The top documents of rhonda-greenapple
Spotlight On: Looking beyond Plavix for evidence of Lipitor type post expiry strategies
384 views
Review Of Strategies To Enhance Outcomes For Patients With Type 2 Diabets
604 views
Obesity: Effective Treatment Requires Change in Payers\' Perspective
751 views
Roadmap to reimbursement and access
1.079 views
Payers Insights Into Future Oncology Management
661 views
AHDB_Payers Collaborate with Providers To Adopt Oncology Pathways, New Care Delivery Models
116 views
How Payers View Pfizer\'s Rheumatoid Arthritis Pill
114 views
Spotlight On: Delivering payer-value early in the drug development process; the role of FDA AdCom panels
130 views
New Treatment For Low Testosterone Protects Fertility
557 views
View Points: Could Pfizer\'s tofacitinib beat expectation and gain approval next month as a second-line therapy?
158 views
Looking beyond Plavix for evidence of Lipitor-type post-expiry strategies
138 views
Analysis: Drug Costs Become Bigger Issue In Cancer Care
110 views
Why Pfizers Rheumatoid Arthritis Pill May Not Be A Sure Bet
213 views
ASCO 2010: Payer Trends in Oncology Management and Latest Clinical Trial Data
373 views
Vbcc Aco Article
163 views
First Word Pharma View Points Commercial Prospects In The Obesity Market Physician And Analyst Observations
126 views
Pfizer’s Rheumatoid Arthritis Pill Not A Slam Dunk
121 views
Payers likely to throw up hurdles to Pfizer\'s new RA drug
111 views
Pfizer Tactics To Combat Generic Drugmakers Financial Times Dec 5, 2011
373 views
Tofacitinib to Be Positioned After Anti-TNFs, Say Payers Based on FDA Panel Review Reuters
131 views
Next >